Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Hiller

Orthopaedic Surgery Aventura, FL Medical Doctor

NPI 1407121833 CMS profile 1391287

21097 Ne 27Th Ct Ste 320, Aventura, FL 33180

Open in the dashboard

General payments

$91,314

378 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andrew Hiller of Aventura, FL is reported in the CMS Open Payments database as having received $91,314 across 378 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,879 77
2024 General $56,555 75
2023 General $23,148 38
2022 General $3,151 109
2021 General $1,333 28
2020 General $993 10
2019 General $2,254 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Hiller
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Andrew Hiller were reported at $3,879. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Andrew Hiller Orthopaedic Surgery median Middle half National median
2019 $2,254 $644 $140–$2,844 $163
2020 $993 $312 $75–$1,860 $114
2021 $1,333 $520 $117–$2,495 $132
2022 $3,151 $598 $128–$2,731 $149
2023 $23,148 $461 $128–$2,264 $160
2024 $56,555 $497 $134–$2,475 $164
2025 $3,879 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Citieffe, Inc. $74,846 11 payments
  2. BIOTRONIK NRO, Inc. $5,271 117 payments
  3. Abbott Laboratories $2,515 90 payments
  4. Stryker Corporation $1,890 35 payments
  5. Southern Edge Orthopaedics, Inc. $1,610 2 payments
  6. Catalyst OrthoScience $956 9 payments
  7. DePuy Synthes Sales Inc. $558 13 payments
  8. FX Shoulder USA, Inc $525 1 payment
  9. Smith+Nephew, Inc. $441 12 payments
  10. Encore Medical, LP $418 5 payments
  11. Other $2,284 83 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $68,000 9 payments
  2. Food and Beverage $14,309 362 payments
  3. Travel and Lodging $7,395 5 payments
  4. Education $1,610 2 payments
Products named General payments · program years 2019–2025
  1. EBA One $16,500 1 payment
  2. Dolphix $11,000 1 payment
  3. Estremo $7,500 1 payment
  4. Prospera Not Applicable $2,368 55 payments
  5. PROCLAIM $2,297 80 payments
  6. Prospera Not Applicable $1,959 43 payments
  7. BIOTRONIK $786 15 payments
  8. Catalyst CSR Shoulder System $783 7 payments
  9. R1 Reverse Shoulder System $525 4 payments
  10. Regeneten $331 7 payments
  11. Other $6,664 187 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

462

Median for Orthopedic Surgery: 203

Drug cost

$3,063

Median for Orthopedic Surgery: $1,433

Branded share of claims

21.9%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 55 $986
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 86 $574
Methocarbamol Generic 45 $396
Gabapentin Generic 106 $376
Doxycycline Monohydrate Generic 12 $175
Meloxicam Generic 85 $168
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 15 $140
Tramadol Hcl Generic 41 $135
Methylprednisolone Generic 17 $114

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 103 billing codes

Paid by Medicare

$170,208

Of which drugs: $5,187

Medicare patients

381

Average age 78

Services billed

1,443

239 women, 142 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 72%
Ischemic heart disease 38%
Depression 33%
Diabetes 32%
Osteoporosis 28%
Chronic kidney disease 25%
COPD 25%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose J7321 Office 39 94 $5,180
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 28 66 $6

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

378 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record